🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Use of Flozins (Empagliflozin/Dapagliflozin) for Prevention of AKI

Recruitingn/aAges 18 Years - anyAllCollegium Medicum w Bydgoszczy
NCT07231939 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

All consecutive patients hospitalized from 01.01.2020 to 30.09.2025 who underwent coronary angiography or PCI will be eligible for inclusion. The final analysis will be limited to individuals in whom the volume of ICM administered during the index procedure was between 50 and 500 mL and for whom both pre- and post-procedure serum creatinine measurements were available. The primary objective of the study is the effect of short-term and long-term SGLT2i therapy on the occurrence of CI-AKI in patients undergoing diagnostic or therapeutic procedures with ICM.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * all consecutive patients who underwent PCI or coronary angiography during the study period for whom the variables required for the analysis are available Exclusion Criteria: * unavailability of variables required for the analysis, volume * contrast agent volume \<50 mL or \>500 mL.
💊

What it tests

  • Flozin
📍

Where

1 site
Collegium Medicum w Bydgoszczy
Bydgoszcz, Poland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy